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This study examined whether supplementing the diet with a commercial supplement containing 
zinc magnesium aspartate (ZMA) during training affects zinc and magnesium status, anabolic and 
catabolic hormone profiles, and/or training adaptations. Forty-two resistance trained males (27±9 
yrs; 178±8 cm, 85±15 kg, 18.6±6% body fat) were matched according to fat free mass and 
randomly assigned to ingest in a double blind manner either a dextrose placebo (P) or ZMA 30-60 
minutes prior to going to sleep during 8-weeks of standardized resistance-training.  Subjects 
completed testing sessions at 0, 4, and 8 weeks that included body composition assessment as 
determined by dual energy X-ray absorptiometry, 1-RM and muscular endurance tests on the 
bench and leg press, a Wingate anaerobic power test, and blood analysis to assess 
anabolic/catabolic status as well as markers of health.  Data were analyzed using repeated 
measures ANOVA.   Results indicated that ZMA supplementation non-significantly increased 
serum zinc levels by 11 – 17% (p=0.12).  However, no significant differences were observed 
between groups in anabolic or catabolic hormone status, body composition, 1-RM bench press and 
leg press, upper or lower body muscular endurance, or cycling anaerobic capacity.  Results 
indicate that ZMA supplementation during training does not appear to enhance training adaptations 
in resistance trained populations.  Journal of the International Society of Sports Nutrition.  
1(2):12-20, 2004. 
 





Zinc is an essential trace element involved in 
a range of vital biochemical processes and is 
required for the activity of more than 300 
enzymes.  Zinc-containing enzymes 
participate in many components of 
macronutrient metabolism, particularly cell 
replication. In addition, zinc-containing 
enzymes such as carbonic anhydrase and 
lactate debydrogenase are involved in  
 
exercise metabolism while superoxide 
dismutase protects against free radical 
damage.  Zinc deficiencies have been shown 
to be higher in athletes and/or individuals 
who recreationally train 1- 3.  Zinc 
deficiencies in athletes have been suggested 
to contribute to impaired immune function 
and decreased performance 1, 4- 6.  
 
Magnesium is a ubiquitous element that 
plays a fundamental role in many cellular 
reactions.  More than 300 metabolic 
reactions require magnesium as a cofactor. 
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Some important examples include 
glycolysis, fat and protein metabolism, 
adenosine triphosphate synthesis, and second 
messenger system.  Magnesium also serves 
as a physiological regulator of membrane 
stability and in neuromuscular, 
cardiovascular, immune, and hormonal 
function. It also appears that there is a 
relationship between magnesium levels and 
cortisol, which has been reported to have 
negative effects on strength gains and 
muscle mass during training.  A 1984 7 study 
found that 14 days of magnesium 
supplementation decreased cortisol which 
would theoretically reduce catabolism during 
training.  Another study reported similar 
results concluding that magnesium 
supplementation reduced the stress response 
without affecting competitive potential 8.   
 
Athletes have been reported to have lower 
levels of zinc and magnesium possibly due 
to increased sweating while training or 
inadequate intake in their  
diets 2, 3, 9-12.  Additionally, zinc and 
magnesium supplementation has been 
reported to have positive effects on 
resistance training athletes 13-16.  
Theoretically, zinc and magnesium 
supplementation may enhance anabolic 
hormonal profiles, reduce catabolism, 
improve immune status, and/or improve 
adaptations to resistance training.  In support 
of this theory, Brilla and Conte 13 reported 
that ZMA supplementation during off-season 
football resistance training promoted 
significant increases in testosterone, IGF-1, 
and muscle strength.  However, it is clear 
that more research is needed before 
conclusions can be drawn.  The purpose of 
this study was to determine whether 
supplementing the diet with a commercially 
available supplement containing ZMA 
during training affects zinc and magnesium 
status, anabolic and catabolic hormone 





Subjects.  Forty-two resistance-trained male 
subjects participated in this study.   Subjects 
had to have at least of one year prior 
resistance training at a frequency of three 
times per week to be considered for this 
study.  Subjects were excluded from 
participation if they were not between 18 – 50 
years of age; had reoccurring or chronic joint 
problems; were diagnosed with 
cardiovascular or pulmonary disorders and/or 
disease; had abnormal heart rate or blood 
pressure; had less than one year of training 
experience; and/or had been recently 
instructed by a physician not to participate in 
high intensity exercise.  A physical readiness 
questionnaire was completed to assess general 
health of the participant.  Subjects were not 
currently (or in the past six months) taking 
dietary supplements containing creatine, 
glutamine, arginine, HMB, androstendione, 
thermogenics, or any other ergogenic 
supplement.  Subjects meeting eligibility 
criteria were informed of the requirements of 
the study and signed an informed consent 
statement in compliance with the Human 
Subjects Guidelines of Baylor University and 
the American College of Sports  
Medicine.  Subjects were descriptively 27±9 
years; 178±8 cm, 85.15 kg, and  
18.6±6% body fat.  
 
Study Design.  This study was conducted as a 
randomized, double blind, placebo controlled 
clinical trial.  Subjects completed two 
familiarization sessions one week prior to 
baseline testing.    During the familiarization 
sessions, subjects completed a health history 
questionnaire, personal information sheet, and 
signed an informed consent statement.  In 
addition, subjects completed one set of leg 
press and bench press as well as a Wingate 
anaerobic power test.  Each participant was 
given personal instruction on how to fill out 
their training and diet logs.  Diet logs were 
kept in order to ensure caloric intake did not 
differ significantly between groups.  Training 
logs were kept to document number of sets, 
repetitions and weight used during each 
training session.  This was done to calculate 
training volume for each participant. 
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Subjects were then scheduled to report to the 
lab for baseline testing (T1). Participants were 
instructed to refrain from exercise for 48 
hours before each testing session and fast for 
10 hours prior to donating blood.  
Additionally, subjects were instructed to keep 
a four day diet record (including one weekend 
day) prior to each testing session.  Testing 
sessions included assessment of body weight 
and body composition, procurement of fasting 
blood samples, and performing 1-RM and 
80% of 1-RM tests on the bench press and leg 
press and a Wingate anaerobic power test.  
Subjects were then randomized to ingest 
placebo or ZMA supplements and to begin 
training as described below.  Participants 
returned to the lab after four (T2) and eight 
weeks (T3) of training. 
 
Testing Procedures.  Nutritional records were 
evaluated and analyzed by a registered 
dietitian using the Food Processor nutritional 
analysis software (ESHA Research Inc., 
Salem, OR).   Height was measured using 
standard anthropometry and total body weight 
was measured using a calibrated electronic 
scale with a precision of ± 0.02 kg 
(Bridgeview, Illinois).  Total body water was 
estimated using a Xitron 4200 Bioelectrical 
Impedance Analyzer (Xitron Technologies 
Inc., San Diego, CA).   The BIA method has 
been determined to be a valid measure for 
total body water 17.  Whole-body (excluding 
cranium) composition was estimated by 
certified personnel using a Hologic QDR-
4500W dual-energy x-ray absorptiometry 
(DEXA) using Hologic software version 
9.80C (Waltham, MA).  This test evaluates 
body composition and body density by 
scanning the entire body with a low dose of 
radiation taking approximately 6 min.  An 
analysis of the subject's fat mass, soft tissue 
(muscle) mass, and bone mass was provided 
and used to determine body composition 
changes throughout the duration of the study.  
The DEXA scans regions of the body (right 
arm, left arm, trunk, right leg, left leg) to 
determine bone mass, fat mass and lean mass 
within each region.  The scanned bone, fat, 
and lean mass for each region is then 
subtotaled to determine whole-body 
(excluding cranium) values.  Percent body fat 
was determined by dividing the amount of fat 
mass by the total scanned mass (bone mass, 
fat mass and lean mass).  Test-retest 
reliability studies performed on male athletes 
with this DEXA machine yielded a mean 
deviation for total BMC and total fat free/soft 
tissue mass of 0.31% with a mean intra-class 
correlation of 0.985.  This method of 
determining body composition has been 
shown to be valid 18.   
 
Subjects then donated approximately 25 ml of 
fasting blood using venipuncture techniques 
of an antecubital vein in the forearm 
according to standard procedures.  Two 10 
mL serum separation (SST) vacutainers and 
one 5 mL anticoagulant tube containing K3 
(EDTA) vacutainer was inserted for blood 
collection using multiple sample phlebotomy 
techniques.  Serum from the SST were 
centrifuged at 5,000 rev x min-1 for 10 min 
using a Biofuge 17R centrifuge (Heraeus Inc., 
Germany).  Serum from both SSTs was 
transferred into three microcentrifuge tubes 
and frozen at –80o C for subsequent analysis.  
Remaining serum was transferred from the 
SST and placed into a sterile collection tube.  
Serum and whole blood samples (EDTA) 
were refrigerated and sent to Quest 
Diagnostics Labs (Dallas, TX).  A complete 
31 panel clinical chemistry profile and 
various markers of muscle/protein 
breakdown, shown in Table 1, was run on 
serum samples using the Technicon DAX 
model 96-0147 automated chemistry analyzer 
(Technicon Inc. Terry Town, NY) following 
standard clinical procedures.  Whole blood 
cell counts with percent differentials were run 
on whole blood samples using a Coulter 
STKS automated analyzer using standard 
procedures (Coulter Inc., Hialeah, FL).  
These analyzers were calibrated daily to 
controls according to manufacturer’s 
recommendations and federal guidelines for 
clinical diagnostic laboratories.  Test to test 
reliability of performing these assays ranged 
from 2 to 6% for individual assays with an 
average variation of ± 3%.  Samples were run 
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in duplicate to verify results if the observed 
values were outside control values and/or 
clinical norms according to standard 
procedures.  Total and free testosterone, IGF-
1, growth hormone, and cortisol levels were 
assayed in duplicate in the Exercise 
Biochemical Nutrition Laboratory (EBNL) 
using standard ELISA techniques.              
Test to test reliability of performing these 
assays were ± 3-5%.   Serum zinc and 
magnesium levels were assayed using 
standard procedures by the Department of 
Human Nutrition at The Ohio State 
University under the supervision of Robert 
DiSilvestro, PhD.  Test to test reliability of 
performing these assays were ± 2-4%. 
 
 
Table 1.  Metabolic and clinical chemistry panels and various hormones analyzed 
Comprehensive Metabolic Panel Complete Blood Count 
Sodium  White blood cell (WBC) count 
Potassium Red blood cell (RBC) count  
Calcium Hemoglobin.   
Chloride Hematocrit 
Carbon Mean corpuscular volume (MCV) 
Glucose  Mean corpuscular hemoglobin (MCH) blood cell. 
Blood urea nitrogen (BUN) 
Mean corpuscular hemoglobin concentration 
(MCHC) 
Creatinine Red cell distribution width (RDW)  
BUN/creatinine ratio Platelet count 
Total protein  Neutrophils 
Albumin Lymphocytes 
Globulin Monocytes 
Albumin/globulin ratio Eosinophils 
Bilirubin Basophils 
Alkaline phosphatase Lipid panel 
Aspartate aminotransferase (AST) Triglycerides 
Alanine aminotransferase (ALT)  High-density lipoprotein (HDL) 
Gamma glutamyl transpeptidase 
(GGT) Low-density lipoprotein (LDL) 
Lactate dehydrogenase  Cholesterol to HDL ratio (Total/HDL) 
Uric acid  Hormones 
Creatine kinase Total testosterone 
  Free testosterone 
  IGF-1 
  Growth hormone 
  Cortisol 
 
 
Subjects warmed-up (2 sets of 8 – 10 
repetitions at approximately 50% of 
anticipated maximum) on the bench press. 
Subject’s then performed successive 1 RM 
lifts starting at about 70% of anticipated 1-
RM and increasing by 5 – 10 lbs until the 
subject reached their 1-RM.  After the 
acquisition of max the participant rested five 
minutes and completed as many repetitions as 
possible at 80% 1-RM to asses’ muscular 
endurance.  Subjects were instructed on 
proper technique and mechanics of the 
movement.  Hand position was also recorded 
to ensure test to test reliability.  Subjects then 
rested for 10 minutes and warmed-up on the 
Nebula 45° Leg press (2 sets of 8 – 10 
repetitions at approximately 50% of 
anticipated maximum).  Subjects then 
performed successive 1-RM lifts on the leg 
press starting at about 70% of anticipated 1-
RM and increasing by 10 – 25 lbs until 
reaching the subject’s 1-RM.  Subjects then 
perform an 80% of 1-RM endurance 
repetition tests on the hip/leg sled. Foot 
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placement and sled height were recorded to 
ensure test to test reliability.  All strength 
testing was supervised by a Certified Strength 
and Conditioning Specialist (CSCS).  Test to 
test reliability of performing these strength 
tests on resistance-trained subjects in our 
laboratory have yielded low mean coefficients 
of variation and high reliability for the bench 
press (1.9%, intraclass r = 0.94) and leg 
press/hip sled (0.7%, intraclass r = 0.91).  
 
Subjects then performed a single standardized 
Wingate cycle ergometry test to assess 
anaerobic capacity and power.  This test 
consisted of having each participant sprint in 
an all out fashion on the bicycle ergometer for 
30-sec against a standard workload of 0.075 
kg/kg of body weight.  Correlation 
coefficients of test-retest reliability for 
absolute peak power and mean power has 
been found to be r = 0.692 and r = 0.950, 
respectively. 
 
Supplementation Protocol.  Subjects were 
matched into two groups according to fat free 
mass, age, and resistance training experience. 
Subjects were then randomly assigned to 
receive in a double blind manner a dextrose 
placebo or Z-Mass PM™ (Cytodyne 
Technologies, Lakewood, NJ).  Subjects 
ingested 4 capsules a day on an empty 
stomach 30-60 minutes prior to going to bed 
for 8-weeks according to label instructions. 
Each daily dose of  Z-Mass PM™ contains 11 
mg of Vitamin B-6 (pyridoxine hcl), 450 mg 
of magnesium (as magnesium aspartate), 30 
mg of zinc (as monomethionine and 
aspartate), 10 mg of potassium (as potassium 
aspartate), and 706 mg of a proprietary blend 
of mucuna pruriens (seeds) standardized for 
50 mg of L-Dopa (purported as a muscle 
relaxant) and Polypodium Vulare/Suma root 
(herb) standardized for 30 mg of 20-
hydroxyecdysone (a plant sterol purported to 
reduce catabolism).  Supplementation 
compliance was monitored on a weekly basis 
by a research nurse as well as by having the 
subjects return the bottles and left over 
supplement at the end of 4 and 8 weeks of 
supplementation.  The pill count method was 
used to determine supplement usage and 
subject compliance.  On a weekly basis 
subjects were asked to complete a “weekly 
follow-up assessment” chart that addressed 
possible symptoms or side effects related to 
the supplementation and training. 
 
Training Protocol.   Subjects participated in a 
periodized 4-day per week resistance-training 
program split into two upper and two lower 
extremity workouts per week for a total of 8-
weeks.  The subjects performed an upper 
body resistance-training program consisting 
of nine exercises (bench press, lat pull, 
shoulder press, seated rows, shoulder shrugs, 
chest flies, biceps curl, triceps press down, 
and abdominal curls) twice per week and a 
seven exercise lower extremity program (leg 
press or squat, back extension, step ups, leg 
curls, leg extension, heel raises, and 
abdominal crunches) performed twice per 
week.  Subjects performed 3 sets of 8 
repetitions during weeks 0 – 4 with as much 
weight as they can lift and 3 sets of 10 
repetitions during weeks 4 – 8 with as much 
weight as they could handle (typically 60 – 
80% of 1-RM).  Rest periods between 
exercises were no longer than 3 minutes and 
rest between sets were no longer than 2 
minutes monitored with a standardized timer.  
Each participant was given instruction on 
technique by a Certified Strength and 
Conditioning Specialist (CSCS). 
 
Statistical Analysis.   Dependent variables 
were analyzed by univariate analysis of 
variance (ANOVA) with repeated measures 
using SPSS version 11.5 software (Chicago, 
IL).  Due to loss of some frozen samples, 
serum zinc, magnesium, and hormone levels 
were determined on a subset of 26 subjects 
(n=13 P, n=13 ZMA).  Data are presented as 
means and + standard deviation changes form 
baseline for the P and ZMA groups, 
respectively. Data were considered 
significantly different when the probability of 
error was < 0.05.  Power analysis in a 2x3 
design indicates that an n-size of 20 per group 
yields high power (>0.9) for delta values of 
0.75 to 1.25. 





Medical Monitoring, Nutritional and 
Training Data.   No significant clinical side 
effects, related or unrelated to the study, were 
reported to the research nurse by any subject 
throughout the course of the study.  All 
subjects tolerated both the training and 
supplementation protocols without any 
problems.  No significant differences were 
observed between groups total caloric intake 




General Markers.  No significant differences 
were observed between groups in total 
protein, albumin, globulin, glucose, 
electrolytes, liver enzymes, lipid profiles, 
total bilirubin, hemoglobin, hematocrit, red 
blood cells or white blood cells.   
 
Plasma Zinc & Magnesium Levels.  Figure 1 
illustrates the changes observed in plasma 
zinc levels between the placebo and ZMA 
groups.   Plasma zinc levels were within 
normal ranges and were non-significantly 
increased by 12-17% after supplementation in 
the ZMA group (P T1 1.08±0.2, T2 
1.02±0.14, T3 1.07±0.25; ZMA T1 
1.04±0.24, T2 1.15±0.27, T3 1.20±0.23, 
µg/ml, p=0.12).  Magnesium levels were also 
within normal ranges and were not 
significantly affected by supplementation (P 
T1 26.5±2.3, T2 27.2±2.5, T3 27.6±2.3; ZMA 
T1 26.9±1.7, T2 28.0±2.7, T3 26.9±3.6 
µg/ml, p=0.40). 
 
Anabolic and Catabolic Hormones.  Figure 2 
shows changes in anabolic and catabolic 
hormones observed between the two groups 
during the study.   No significant differences 
were seen between groups in mean IGF-1 (P -
25.7±60; ZMA 0.2±41 ng/mL, p=0.23), total 
testosterone (P -0.12±1.3; ZMA -0.47±0.9 
ng/mL, p=0.50), free testosterone (P -
1.62±5.5; ZMA -1.68±5.3 pg/mL, p=0.96), 
cortisol (P -1.06±5.2; ZMA  0.41±6.3 µg/dL, 
p=0.54), total testosterone to cortisol ratio (P -
0.014±0.14; ZMA -0.011±0.2, p=0.97), or 
growth hormone (P 0.03±0.19; ZMA 















Figure 1. Change in plasma zinc levels (mean + SD) 
between two groups (grey = placebo, black = ZMA) 





















Figure 2. Change in anabolic and catabolic hormones 
(mean + SD) between two groups (grey = placebo, 
black = ZMA) over eight weeks of standardized 
resistance training 
 
Body Composition.  Figure 3 presents body 
composition changes observed between the 
two groups over time.  Although some 
potentially favorable trends were observed, no 
statistically significant differences were seen 
between groups in mean changes in body 
mass (P -0.17±2.0; ZMA 0.27±2.0 kg, 
p=0.61), scanned fat free mass (P 0.15±1.3; 
ZMA 0.73±1.5 kg, p=0.20), scanned fat mass 
(P -0.08±1.0; ZMA -0.74±1.5 kg, p=0.12), or 
percent body fat (P -0.07±1.2; ZMA -
0.79±1.5%, p=0.10).   
















Figure 3. Change in body composition (mean + SD) 
between two groups (grey = placebo, black = ZMA) 
over eight weeks of standardized resistance training 
 
Performance.   No statistically significant 
changes were observed between groups in 
mean bench press 1-RM (P 3.6±5.5 kg and 
ZMA 5.6±5.9 kg, p=0.24), leg press 1-RM (P 
24.6±25 kg and ZMA  25.4±32 kg,  p=0.92), 
bench press lifting volume (P -51±206kg; 
ZMA 4±186 kg, p=0.38), or leg press lifting 
volume (P 480±1,022kg; ZMA 724±1,258 kg,  
p=0.48).   Likewise, no significant differences 
were observed in sprint peak power (P 
0.9±10%;  ZMA 3.6±10 %, p=0.40), total 
work (P 8.0±29; ZMA 1.1±12.2 %, p=0.34), 





The major findings of this study was that 
dietary supplementation of a commercially 
available ZMA supplement resulted in a non-
significant 12-17% increase in serum zinc 
levels but did not appear to effect anabolic or 
catabolic responses to resistance training, 
body composition, or training adaptations.  
These findings do not support contentions that 
ZMA supplementation during training 
increases muscle mass and/or enhances 
training adaptations.  The following provides 
additional insight to results observed. 
 
Zinc and Magnesium Status.  Athletes have 
been reported to have low zinc and 
magnesium levels which have been found to 
negatively impact performance 1, 4-6.   Brilla 
and Conte 13 reported that ZMA 
supplementation (i.e., 30 mg zinc 
monomethionine aspartate, 450 mg 
magnesium aspartate, and 10.5 mg vitamin B-
6) promoted a 30% increase in plasma zinc 
levels (0.8±0.1 to 1.04±0.14 µg/mL) and a 
6.1% increase in plasma magnesium levels 
(19.43±1.2 to 20.63±0.73 µg/mL).  In the 
present study, fasting zinc and magnesium 
levels were within normal ranges (1.04±0.24 
to 1.08±0.2 µg/mL) and training did not 
negatively impact on zinc or magnesium 
status.  ZMA supplementation promoted only 
a modest but non-significant increase in 
plasma zinc levels (12-17%) while 
magnesium levels were not significantly 
affected.  These findings indicate that within 
the population and sample tested, ZMA 
supplementation had no discernable effects on 
plasma zinc or magnesium status.  While the 
present study did not assess tissue levels of 
these minerals, these findings suggest that 
ZMA supplementation may not be needed or 
beneficial in this population of athletes.  In 
support of this finding, Lukasi 1 concluded 
that although some studies 2, 3, 9-12 have 
suggested that zinc and magnesium levels are 
diminished in athletes, most athletes get 
adequate dietary intake of booth zinc and 
magnesium.    
  
Training Adaptations.   ZMA supplement-
ation has been purported to increase zinc and 
magnesium status, anabolic hormones, and 
promote greater gains in strength during 
training.  In support of this contention, Brilla 
and Conte 13 reported that ZMA 
supplementation significantly increased free 
testosterone, IGF-1, and isokinetic strength 
gains during training.  Results of this study do 
not support these findings.  In this regard, 
ZMA supplementation had no significant 
effects on total and free testosterone, IGF-1, 
growth hormone, cortisol, the ratio of cortisol 
to testosterone, or muscle and liver enzymes 
in response to training.  Moreover, no 
significant effects were observed between 
groups in changes in 1-RM strength, upper or 
lower body muscle endurance, or anaerobic 
sprint capacity.  Interestingly, while some 
contend that ZMA supplementation may 
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increase muscle mass during training, the 
Brilla and Conte 13 paper reported that ZMA 
supplementation had no effect on body mass 
changes during training.  Results of the 
present study support these findings in that 
ZMA supplementation had no significant 
effects on body mass or DEXA determined 
body composition values.  However, it should 
be noted that some potentially favorable 
trends were observed in fat free mass, fat 
mass, and body fat that deserve additional 
study.    
 
Summary.  Results of the present study do 
not support contentions that ZMA 
supplementation increases zinc or magnesium 
status and/or affects training adaptations in 
experienced resistance trained males with 
normal zinc status.  These findings are in 
contrast with the notion that ZMA 
supplementation can increase zinc and 
magnesium status, anabolic hormone status, 
and/or strength gains during training.  These 
findings refute claims that ZMA 
supplementation in the amount and manner 
investigated provides ergogenic value to 
experienced resistance trained athletes.  
Whether higher levels of ZMA is needed to 
promote these adaptations in experienced 
resistance-trained males; ZMA 
supplementation may influence zinc and 
magnesium status and/or training adaptations 
in individuals with low zinc and magnesium 
status; and/or, whether ZMA supplementation 
may have therapeutic and/or ergogenic value 
in other populations (e.g., untrained, females, 
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